{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:18:58Z","timestamp":1786979938142,"version":"build-2736575974"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s00277-025-06264-7","type":"journal-article","created":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T01:11:17Z","timestamp":1753405877000},"page":"4245-4249","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Hyperhemolysis in a sickle cell disease patient in pregnancy"],"prefix":"10.1007","volume":"104","author":[{"given":"Kristen","family":"Warncke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alecia","family":"Nero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravindra","family":"Sarode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian D.","family":"Adkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Bavli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,25]]},"reference":[{"key":"6264_CR1","doi-asserted-by":"publisher","unstructured":"Society for Maternal-Fetal Medicine, Sinkey RG, Ogunsile FJ, Kanter J, Bean C, Greenberg M, Society for Maternal-Fetal Medicine Publications Committee (2023). Electronic address: pubs@smfm.org. Society for Maternal-Fetal Medicine Consult Series #68: Sickle cell disease in pregnancy. Am J Obstet Gynecol. Oct 21:S0002-9378(23)00767-6. https:\/\/doi.org\/10.1016\/j.ajog.2023.10.031. Epub ahead of print. PMID: 37866731","DOI":"10.1016\/j.ajog.2023.10.031"},{"key":"6264_CR2","doi-asserted-by":"publisher","first-page":"S512","DOI":"10.1016\/j.amepre.2009.12.022","volume":"38","author":"KL Hassell","year":"2010","unstructured":"Hassell KL (2010) Population estimates of sickle cell disease in the U.S. American. Am J Prev Med 38:S512\u2013S521","journal-title":"Am J Prev Med"},{"key":"6264_CR3","doi-asserted-by":"publisher","unstructured":"ACOG Committee on Obstetrics. ACOG Practice Bulletin No. 78: hemoglobinopathies in pregnancy. Obstet Gynecol (2007);109(1):229\u2013\u200937. https:\/\/doi.org\/10.1097\/00006250-200701000-00055. PMID: 17197616","DOI":"10.1097\/00006250-200701000-00055"},{"key":"6264_CR4","doi-asserted-by":"publisher","first-page":"3316","DOI":"10.1182\/blood-2014-11-607317","volume":"125","author":"D Meeks","year":"2015","unstructured":"Meeks D, Seed PT et al (2015) Adverse maternal and perinatal outcomes in pregnant women with sickle cell disease: systematic review and meta-analysis. Blood 125:3316\u20133325","journal-title":"Blood"},{"key":"6264_CR5","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1080\/17474086.2022.2151432","volume":"15","author":"R Bou Fakhredin","year":"2022","unstructured":"Bou Fakhredin R, Taher AT (2022) Pregnancy and sickle cell disease: an overview of complications and suggested perinatal care. Expert Rev Hematol 15:1055\u20131061","journal-title":"Expert Rev Hematol"},{"key":"6264_CR6","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1080\/17474086.2022.2151432","volume":"15","author":"NM Moukalled","year":"2022","unstructured":"Moukalled NM, Bou Fakhredin R, Taher AT (2022) Pregnancy and sickle cell disease: an overview of complications and suggested perinatal care. Expert Rev Hematol 15:1055\u20131061","journal-title":"Expert Rev Hematol"},{"key":"6264_CR7","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.ajog.2016.05.032","volume":"215","author":"K Kuo","year":"2016","unstructured":"Kuo K, Caughey AB (2016) Contemporary outcomes of sickle cell disease in pregnancy. Am J Obstet Gynecol 215:505.e1-505.e5","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"6264_CR8","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1111\/bjh.18825","volume":"201","author":"JW Jacobs","year":"2023","unstructured":"Jacobs JW, Stephens LD, Allen ES, Binns TC, Booth GS, Hendrickson JE, Karafin MS, Tormey CA, Woo JS, Adkins BD (2023) Epidemiological and clinical features, therapeutic strategies and outcomes in patients with hyperhaemolysis: a systematic review. Br J Haematol 201(6):1025\u20131032. https:\/\/doi.org\/10.1111\/bjh.18825Epub 2023 Apr 19. PMID: 37074146","journal-title":"Br J Haematol"},{"issue":"Supplement 1","key":"6264_CR9","doi-asserted-by":"publisher","first-page":"4282","DOI":"10.1182\/blood-2021-152788","volume":"138","author":"S Aroob Sweidan","year":"2021","unstructured":"Aroob Sweidan S, Vuyyala P, Xie M, Alhyari VS, Dabak, Zaher K, Otrock (2021) Hyperhemolysis syndrome in SCD patient: reminder of a rare but life-threatening complication of blood transfusion. Blood 138(Supplement 1):4282. https:\/\/doi.org\/10.1182\/blood-2021-152788","journal-title":"Blood"},{"key":"6264_CR10","doi-asserted-by":"publisher","unstructured":"Madu AJ, Ugwu AO (June 2021) Chilota Efobi; Hyperhaemolytic Syndrome in Sickle Cell Disease: Clearing the Cobwebs. Med Princ Pract 30(3):236\u2013243. https:\/\/doi.org\/10.1159\/000512945","DOI":"10.1159\/000512945"},{"key":"6264_CR11","doi-asserted-by":"publisher","unstructured":"Aygun B, Padmanabhan S, Paley C, Chandrasekaran V (2002) Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions. Transfusion 42(1):37\u201343. https:\/\/doi.org\/10.1046\/j.1537-2995.2002.00007.x. PMID: 11896310","DOI":"10.1046\/j.1537-2995.2002.00007.x"},{"key":"6264_CR12","doi-asserted-by":"publisher","unstructured":"Aragona EMD, Kelly MJ, MD MPH. Hyperhemolysis in Sickle Cell Disease. Journal of Pediatric Hematology\/Oncology 36(1):p e54-e56, January 2014.| https:\/\/doi.org\/10.1097\/MPH.0b013e31828e529f","DOI":"10.1097\/MPH.0b013e31828e529f"},{"issue":"1","key":"6264_CR13","doi-asserted-by":"publisher","first-page":"101","DOI":"10.5811\/cpcem.2020.12.50349","volume":"5","author":"JA Kalter","year":"2021","unstructured":"Kalter JA, Gupta R, Greenberg MR, Miller AJ, Allen J (2021) Hyperhemolysis Syndrome in a patient with Sickle Cell Disease: a Case Report. Clin Pract Cases Emerg Med 5(1):101\u2013104. https:\/\/doi.org\/10.5811\/cpcem.2020.12.50349PMID: 33560964; PMCID: PMC7872616","journal-title":"Clin Pract Cases Emerg Med"},{"issue":"1","key":"6264_CR14","doi-asserted-by":"publisher","first-page":"e13017","DOI":"10.7759\/cureus.13017","volume":"13","author":"K Shankar","year":"2021","unstructured":"Shankar K, Shah D, Huffman DL, Peterson C, Bhagavatula R (2021) Hyperhemolysis Syndrome in a patient with sickle cell disease and acute chest syndrome. Cureus 13(1):e13017. https:\/\/doi.org\/10.7759\/cureus.13017PMID: 33659145; PMCID: PMC7920227","journal-title":"Cureus"},{"issue":"7","key":"6264_CR15","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1111\/trf.16932","volume":"62","author":"C Fuja","year":"2022","unstructured":"Fuja C, Kothary V, Carll TC, Singh S, Mansfield P, Wool GD (2022) Hyperhemolysis in a patient with sickle cell disease and recent SARS-CoV-2 infection, with complex auto- and alloantibody work-up, successfully treated with tocilizumab. Transfusion 62(7):1446\u20131451. https:\/\/doi.org\/10.1111\/trf.16932","journal-title":"Transfusion"},{"issue":"2","key":"6264_CR16","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1182\/bloodadvances.2019001143","volume":"4","author":"ST Chou","year":"2020","unstructured":"Chou ST, Alsawas M, Fasano RM, Field JJ, Hendrickson JE, Howard J, Kameka M, Kwiatkowski JL, Pirenne F, Shi PA, Stowell SR, Thein SL, Westhoff CM, Wong TE, Akl EA (2020) American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support. Blood Adv 4(2):327\u2013355. https:\/\/doi.org\/10.1182\/bloodadvances.2019001143PMID: 31985807; PMCID: PMC6988392","journal-title":"Blood Adv"},{"issue":"4","key":"6264_CR17","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1182\/bloodadvances.2023011301","volume":"8","author":"I Deva Sharma","year":"2024","unstructured":"Deva Sharma I, Kozano\u011flu KI, Ataga A, Benachi S, B\u00fcy\u00fckkurt S, Lanzkron H, Ozdogu S, Pancham LH, Pecker, Susan E, Robinson (2024) Safak Yilmaz Baran, Jo Howard; managing sickle cell disease and related complications in pregnancy: results of an international Delphi panel. Blood Adv 8(4):1018\u20131029. https:\/\/doi.org\/10.1182\/bloodadvances.2023011301","journal-title":"Blood Adv"},{"issue":"10","key":"6264_CR18","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1111\/trf.16003","volume":"60","author":"L Vasanthamohan","year":"2020","unstructured":"Vasanthamohan L, Choo S, Marshall T, Symons YT, Matsui D, Eastabrook G, Solh Z (2020) Peripartum hyperhemolysis prophylaxis and management in sickle cell disease: a case report and narrative review. Transfusion 60(10):2448\u20132455. https:\/\/doi.org\/10.1111\/trf.16003Epub 2020 Aug 26. PMID: 32851670","journal-title":"Transfusion"},{"key":"6264_CR19","unstructured":"National Toxicology Program NTP-CERHR monograph on the potential human reproductive and developmental effects of hydroxyurea. NTP CERHR MON 2008;(21):vii-viii, v, ix-III1. PMID: 19407858"},{"issue":"3","key":"6264_CR20","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3390\/hematolrep14030032","volume":"14","author":"SR Menakuru","year":"2022","unstructured":"Menakuru SR, Priscu A, Dhillon V, Salih A (2022) Acute Hyperhemolysis Syndrome in a patient with known sickle cell Anemia refractory to steroids and IVIG treated with Tocilizumab and Erythropoietin: a Case Report and Review of Literature. Hematol Rep 14(3):235\u2013239. https:\/\/doi.org\/10.3390\/hematolrep14030032","journal-title":"Hematol Rep"},{"key":"6264_CR21","first-page":"193","volume":"34","author":"A Ghosh","year":"2007","unstructured":"Ghosh A, Ayers K (2007) Darbepoetin alfa for treatment of anaemia in a case of chronic renal failure during pregnancy\u2013case report. Clin Exp Obs Gynecol 34:193\u2013194","journal-title":"Clin Exp Obs Gynecol"},{"key":"6264_CR22","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/j.1365-2141.2009.07755.x","volume":"146","author":"A Maccio","year":"2009","unstructured":"Maccio A, Maddedu C, Chessa P, Mantovani G, Galanello R (2009) Use of erythropoiesis stimulating agents for the treatment of anaemia and related fatigue in a pregnant woman with HbH disease. Br J Haematol 146:335\u2013337","journal-title":"Br J Haematol"},{"key":"6264_CR23","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/trf.15562","volume":"60","author":"LE Lee","year":"2020","unstructured":"Lee LE, Beeler BW, Graham BC, Cap AP, Win N, Chen F (2020) Post- transfusion hyperhemolysis is arrested by targeting macro- phage activation with novel use of Tocilizumab. Transfusion 60:30\u201335","journal-title":"Transfusion"},{"key":"6264_CR24","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1080\/01443610601062739","volume":"27","author":"TL Tan","year":"2007","unstructured":"Tan TL, Ahmad H, Jhavar R, Patel R, Harrison C, Oteng- Ntim E (2007) Use of erythropoietin in a pregnant Jehovah\u2019s witness with sickle-cell disease. J Obstet Gynaecol 27:82\u201383","journal-title":"J Obstet Gynaecol"},{"issue":"3","key":"6264_CR25","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1111\/trf.16805","volume":"62","author":"J Meenan","year":"2022","unstructured":"Meenan J, Hall R, Badle S, Chatterjee B, Win N, Tsitsikas DA (2022) Tocilizumab in the management of posttransfusion hyperhemolysis syndrome in sickle cell disease: the experience so far. Transfusion 62(3):546\u2013550. https:\/\/doi.org\/10.1111\/trf.16805Epub 2022 Jan 29. PMID: 35092617","journal-title":"Transfusion"},{"key":"6264_CR26","doi-asserted-by":"publisher","unstructured":"Amal ME, Afifi AM, Saeed GH, Fekry, Mariam A, Mostafa RA, Elmetwally IM, Hamed, Aliaa N, Hussein, Gomaa M, Hasanien (February 2023) Successful management of severe hyperhaemolysis with combined Tocilizumab and Rituximab in Non-transfusion-dependent Thalassaemia: a Case Report. Transfus Med Hemother 2(1):66\u201370. https:\/\/doi.org\/10.1159\/000524743","DOI":"10.1159\/000524743"},{"key":"6264_CR27","doi-asserted-by":"publisher","unstructured":"Diav-Citrin O, Hunnisett L, Sher GD, Koren G (1999) Hydroxyurea use during pregnancy: a case report in sickle cell disease and review of the literature. Am J Hematol 60(2):148\u2013\u200950. https:\/\/doi.org\/10.1002\/(sici)1096-8652(199902)60:2%3C148::aid-ajh12%3E3.0.co;2-i. PMID: 9929109.","DOI":"10.1002\/(sici)1096-8652(199902)60:2%3C148::aid-ajh12%3E3.0.co;2-i"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06264-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-025-06264-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06264-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T07:48:37Z","timestamp":1757663317000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-025-06264-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,25]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["6264"],"URL":"https:\/\/doi.org\/10.1007\/s00277-025-06264-7","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,25]]},"assertion":[{"value":"6 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval was obtained from the ethics committee at University of Texas Southwestern Medical Center. The participant has consented to the submission of the case report to the journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}